Advanced Biomed Inc (NASDAQ:ADVB) shares are trading lower during Wednesday's premarket session. The move follows a massive rally on Tuesday. Investors appear to be taking profits after the stock surged over 51% yesterday.
All-Stock Acquisition Details
The volatility follows an April 2, announcement. The Company entered a Share Purchase Agreement with Acellent Technologies. Advanced Biomed will acquire 100% of the equity interest.
The deal is an all-stock transaction. The Company will issue 270,000 shares of common stock to the seller.
The deal carries an estimated value of $1.08 million. This assumes a share price of $4.00.
Strategic Pivot Into AI
Acellent Technologies provides AI-powered financial verification and audit solutions. This marks a diversification for Advanced Biomed. The Company typically focuses on microfluidic biochip technologies and cancer diagnosis.
Existing products include the AC-1000 and A+CellScan. These devices aid in early cancer screening and treatment staging.
Technical Analysis
At $6.09, ADVB is trading 29.6% above its 20-day simple moving average (SMA), the stock’s average price over the last 20 sessions, which suggests the short-term trend has been strong and extended. It's also trading 0.3% below its 100-day SMA,
The relative strength index (RSI), a momentum gauge, is 72.11.
- Key Resistance: $6.50
- Key Support: $4.50
ADVB Stock Price Activity: Advanced Biomed shares were down 7.36% at $6.04 during premarket trading on Wednesday, according to Benzinga Pro data.
Photo Courtesy: KeyFame on Shutterstock.com